From January 1, 2024 to March 31, 2024, the company has repurchased 729,679 shares, representing 0.99% for $266.97 million. With this, the company has completed the repurchase of 1,995,340 shares, representing 2.7% for $705.31 million under the buyback announced on February 16, 2023.
West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
314.7 USD | -0.16% | -5.05% | -10.63% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.63% | 22.96B | |
-2.26% | 181B | |
+2.05% | 108B | |
-1.31% | 69.41B | |
+14.65% | 46.61B | |
-6.69% | 45.85B | |
+7.97% | 42.61B | |
+18.60% | 30.71B | |
+16.92% | 25.63B | |
-6.87% | 23.32B |
- Stock Market
- Equities
- WST Stock
- News West Pharmaceutical Services, Inc.
- Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.